| 1 |
Evaluation of Circulating MicroRNA-130b as a novel non-invasive biomarker for hepatocellular carcinoma |
2025 |
| 2 |
Role of Prothrombin and Methylenetetrahydrofolate Reductase Gene Polymorphisms as well as Thrombophilia Markers, as Risk Factors for Unexplained Recurrent Miscarriage: A Case-Control Study |
2025 |
| 3 |
Value of fibrinogen, fibrinogen to albumin ratio, and blood cell-derived inflammatory indices in patients with systemic sclerosis: A case–control study |
2025 |
| 4 |
Study of MicroRNA-124 in Patients with Lupus Nephritis. |
2024 |
| 5 |
Assessment of long noncoding RNA CCAT1 using real time-polymerase chain reaction in colorectal cancer patients |
2024 |
| 6 |
Plasma Metadherin mRNA expression in Bladder Cancer |
2024 |
| 7 |
The Assesment of Matrix Metalloproteinase-1 Genotypes Polymorphism as a Risk Factor For Hepatocellular Carcinoma in Chronic Hepatitis C Patients with Liver Cirrhosis |
2024 |
| 8 |
Acute non-AE hepatitis: Causes, characteristics, and predictors of prognosis |
2023 |
| 9 |
Changes in eotaxin-2 and periostin levels in patients with bronchial asthma according to their smoking status: a crosssectional study |
2023 |
| 10 |
Current insight into enteropathogens in flare-up ulcerative colitis. An observational stu |
2023 |
Do you have any questions? 
